Skin Microbiome: The key to treating eczema flares
While the role of the Staphylococcus aureus in eczema flares is well understood in the medical community, there have never been options to target it long term without resistance while sparing the commensal bacteria.
Eczema flare severity is correlated with high Staphyloccous colonization and low microbial diversity
(Kong et al, Genome Res. 2012)
Time (Atopic Dermatitis disease progression)
Benefits of Gladskin with Micreobalance™ Endolysin
Balances the skin microbiome.
Preserves the protective commensal bacteria, including s. epidermidis.
Strengthens the skin barrier.
Patient use study results
German Eczema Patient Society study of self reported outcomes after using Gladskin (European formula) demonstrated 76% of people experienced improvement within a few days.
Speed and degree of response to Gladskin among total subjects
Speed and degree of response to Gladskin among responders
Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta -analysisRead
Gladskin has a robust safety profile
- Gladskin has been on the market in Europe since 2016 without concerning adverse event reports
- Now Gladskin Eczema Cream is manufactured in a cGMP FDA registered manufacturing facility in the U.S.*
- Safety demonstrated in a 100 patient placebo controlled trial
- Passed 21 Day Cumulative Irritation Test
- Passed HRIPT Testing on sensitive skin panel
- Passed phototoxicity panel test
- *Gladskin Eczema Cream available in the U.S. is the same formulation as the product available in Europe with the addition of 0.02% USP colloidal oatmeal.
Gladskin has been used safely throughout Europe since 2016
Instructions for patient and caretaker use
- Gladskin with Micreobalance™ is approved for use without prescription by adults and children 3 months and up
- Use Gladskin twice a day, or more as desired, on skin free of other products
- Wait at least 10 minutes after applying Gladskin before applying other topical products
- Can be used alongside corticosteroids